Latanoprost Comp. Al

Latanoprost, the active ingredient in Latanoprost Comp. Al, is a prostaglandin analog presented as eye drops for ocular use. It lowers intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. Timolol, also present, is a non‑selective beta‑blocker that further reduces aqueous humor production, enhancing pressure control.

GNH USA supplies Latanoprost Comp. Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost Comp. Al is indicated for conditions affecting intra‑ocular pressure within the glaucoma disease family.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. Ocular hypertension: lowers pressure to prevent progression to glaucoma. Secondary glaucoma (e.g., pseudoexfoliative): provides additional pressure reduction when monotherapy is insufficient.

Adverse reactions may occur with ocular administration of Latanoprost Comp. Al.

Common Side Effects: - Eye irritation or burning sensation. - Transient blurred vision. - Conjunctival hyperemia (redness). - Increased eyelash growth. - Periorbital skin darkening. - Mild headache.

Serious or Rare Side Effects: - Persistent ocular inflammation or uveitis. - Severe allergic reaction (angio‑edema, anaphylaxis). - Significant reduction in heart rate or bronchospasm in susceptible patients. - Visual field loss unrelated to pressure control. - Systemic hypotension. - Acute angle‑closure glaucoma (rare).

Patients should be aware of specific safety considerations before using Latanoprost Comp. Al.

Pregnancy: safety not established; avoid unless clearly needed. Breastfeeding: unknown excretion; weigh benefits against potential risks. Respiratory disease: use caution in asthma or COPD due to beta‑blockade. Cardiovascular disease: monitor heart rate and blood pressure. Contact lens wearers: remove lenses before instillation and wait 15 minutes before reinserting. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost Comp. Al may interact with other medications affecting ocular or systemic physiology.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol) – additive systemic beta‑blockade. - Sympathomimetic eye drops – opposing ocular pressure effects. - MAO inhibitors – potential for exaggerated hypotensive response.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives – monitor blood pressure. - Anticholinergic agents – may affect tear production. - Topical corticosteroids – increased risk of ocular hypertension. - Other prostaglandin analogs – avoid concurrent use due to additive side effects.